The U1 snRNP-specific 70K protein is one of the few snRNP proteins from higher eukaryotic cells that is phosphorylated In vivo (1,2). Immunoafflnity purified spliceosomal snRNPs (U1, U2, U5, and U4/U6) were tested for their ability to phosphorylate In vitro the U1-specific 70K protein. 
INTRODUCTION
Splicing of nuclear pre-mRNAs requires the presence of a number of trans-acting factors which associate with a given intron during spliceosome formation (see ref. 3 for recent review). Two classes of splicing factors may be distinguished. One class is comprised oftheUsnRNPs, Ul, U2, U5, andU4/U6. They consist of either one (Ul, U2, U5) or two (U4/U6) snRNA molecules which are associated with 10 to 15 proteins (4) . While a subset of these proteins is common to each of the U-snRNPs, several proteins associate specifically with one snRNP species; Ul snRNPs, for example, contain three particle specific proteins designated 70K, A, and C. The second class of trans-acting splicing factors consists of proteins which are not associated with the snRNPs. While the factors in both classes are essential for constitutive premRNA splicing, some of them, such as ASF/SF2 or Ul snRNP, have also been shown to be involved in alternative splicing events (5) (6) (7) . The exact mechanism whereby these factors influence splice site selection is poorly understood.
A number of splicing factors, including ASF/SF2 (8,9), U2AF(10), SC35 (11) and regulators of Drosophila RNA splicing (reviewed in 12, 13) , and the U1-70K protein (14, 15, 16) share structural features which include an RNA binding domain and a region rich in arginine and serine residues. Recent studies have demonstrated an essential role for the latter domain in the activity of ASF/SF2 and U2AF (10, 17) . ASF/SF2 has recently been shown to belong to a large family of conserved, serine/argininerich, nuclear phosphoproteins (18) . This family has been proposed to consist largely of functionally related proteins. Several members have been identified as splicing factors, suggesting that a number of proteins essential for pre-mRNA splicing exist as phosphoproteins in vivo. Studies with a monoclonal antibody which is known to specifically recognize a phosphorylated epitope and which was also shown to recognize ASF/SF2, provided preliminary evidence that ASF/SF2 may be phosphorylated in vivo (18) (19) (20) . While direct evidence for the phosphorylation of ASF/SF2 is still lacking, the U1-70K protein, on the other hand, has clearly been shown to exist as a phosphoprotein in vivo (1, 2) . Phosphorylation of each of the thirteen 70K protein isoelectric variants has been demonstrated, with all of the variants sharing at least four major phosphorylation sites (2) .
A central role for reversible protein phosphorylation in the regulation of both constitutive and alternative splicing has recently been postulated (21, 22) . Multiple protein phosphorylation events could partially explain the ATP requirement for both spliceosome formation and the subsequent cleavage/ligation steps of premRNA splicing. Several recent studies indicate that the dephosphorylation of splicing factors is required for both steps of the splicing reaction. Tazi et al. have demonstrated through the use of ATP analogs and protein phosphatase inhibitors that the second step of in vitro splicing is blocked in the absence of phosphatase activity (21) . Similarly, Mermoud et al. have demonstrated, through the use of highly specific protein phosphatase inhibitors and purified protein phosphatases, that at least two different serine/threonine phosphatases are essential for pre-mRNA splicing, but not for spliceosome assembly (22) . One target of the serine/threonine phosphatases may be the U1-70K protein. Indeed, splicing complementation studies with Ul snRNP particles containing either phosphorylated or thiophosphorylated 70K protein suggest that dephosphorylation of this Ul-specific protein may be critical for its function as a splicing factor in vitro (23) .
Here, we describe the identification and initial characterization of an snRNP-associated kinase activity which phosphorylates the Ul-specific 70K protein in vitro. Through phosphoamino acid and phosphopeptide analyses, we provide evidence that the snRNP-associated kinase is responsible, at least in part, for 70K phosphorylation in vivo. Protease digestion studies and the use of a synthetic peptide allowed the mapping of 70K protein phosphorylation sites to the arginine-serine rich C-terminal domain of the protein. The results of in vitro phosphorylation studies with purified, recombinant ASF/SF2 and a form arising from alternative splicing and lacking the RS domain, ASF-3 (8), as well as various ASF/SF2 deletion mutants, suggest that diis enzyme may generally recognize the RS-rich domains typical of a number of splicing factors.
MATERIALS AND METHODS

Isolation of snRNPs
The cultivation of HeLa S3 cells and their labeling witĥ P-orthophosphate were carried out as described by Bringmann et al. (24) . Nuclear extracts were prepared either as described by Bringmann et al. (24) (designated SIR extracts) or according to Dignam et al. (25) (designated splicing extracts). SIR extracts lack the high molecular weight U5-specific proteins and contain an, as yet, unidentified protein which we have designated D' (see Figure 1 and reference 26). Ul, U2, U5, and U4/U6 snRNPs were isolated from SIR nuclear extract by immunoaffinity chromatography with an anti-m 3 G antibody as described by Bach et al. (27) . Ul -U6 snRNPs were isolated in an identical manner from splicing extracts except anti-nVjG antibody bound snRNPs were washed and eluted with buffer containing 250 mM, rather than 420 mM, NaCl. Kinase active Ul snRNPs were isolated from the latter snRNP preparation by Mono Q column chromatography as previously described (27) . SnRNPs were dialysed against buffer containing 5 mM Hepes-KOH, pH 7.9, 5% (w/v) glycerol, 25 mM KC1, 1 mM MgCl 2 , 0.05 mM EDTA, 0.5 mM DTE, and 0.5 mM PMSF before use in all phosphorylation experiments.
Preparation of ASF/SF2 and synthetic peptide ASF/SF2 deletion mutants were constructed as described by Zuo and Manley (17) . Deletion mutants A, B, and C (see Figure 6 ) were generated by digestion of the ASF/SF2 RS-rich domain with Hinfl, Apal, and PF/MI, respectively. Mutant D was generated by removing an Apal-Styl fragment from the RS-rich domain. ASF/SF2, ASF-3, and the deletion mutants were expressed and purified from E.coli as previously described (8) . The 32 amino acid long polypeptide (peptide-32) with the sequence DRDRER-RRSHRSERERRRDRDRDRDRDREHKR (corresponding to positions 349-380 of die human U1-70K protein) was synthesized on an Applied Biosystems 430A peptide synthesizer. The peptide was purified before use by Sephadex G25 gel filtration.
Kinase assays
In vitro phosphorylation assays were performed by incubating a mixture of anti-m 3 G purified snRNPs (final concentration of 100-10 ng protein/ml) or Mono Q purified Ul snRNP (final concentration 50 y.% protein/ml) at 37 °C for 30 min in buffer containing 10 mM Hepes-KOH, pH 7.9, 10% (w/v) glycerol, 50 mM KC1, 3 mM MgCl 2 , 0.1 mM EDTA, 0.5 mM DTE, 0.5 mM PMSF and 0.2 mCi/ml (66 nM) gamma-[ 32 P]-ATP (3000 Ci/mmol). ASF/SF2 variants and peptide-32 were added to the aforementioned mixture to a final concentration of 25-50 jtg/ml and 150/ig/ml, respectively. For the negative control, duplicate samples were frozen in liquid nitrogen immediately after gamma-[ 32 P]-ATP addition or, alternatively, diluted 20-fold with PK buffer containing 100 mM Tris-HCl (pH 7.5), 12.5 mM EDTA, 150 mM NaCl and 0.1% (w/v) SDS, and immediately placed on ice.
PAGE analysis of phosphorylated proteins
Protein was isolated from the in vitro kinase assays or in vivo labeled, immunoaffinity purified snRNPs, by extraction with phenol/chloroform essentially as described by Lehmeier et al. (26) . Proteins were fractionated on 7% or 15% discontinuous SDS-polyacrylamide gels as described by Laemmli et al. (28) or by two-dimensional PAGE as previously described (2) .
Phosphoamino acid analysis and tryptic phosphopeptide mapping Tryptic phosphopeptide mapping was performed as previously described (2) . Phosphoamino acid analysis was performed generally as described by Bister et al. (29) . In particular, radiolabeled 70K protein, phosphorylated either in vivo or in vitro, was fractionated by SDS-PAGE and isolated as described for tryptic proteolysis by Woppmann et al. (2) . Lyophilized, radiolabeled 70K protein was then redissolved in 50 yX of 5.7 M HC1 and incubated for 2 h at 110 c C. After evaporation of the acid, hydrolyzed products were separated by two dimensional electrophoresis on cellulose-coated thin-layer plates. Electrophoresis in the first dimension was carried out for 20 min at 2300 V in pH 1.9 buffer [2.2% (v/v) formic acid, 7.8% (v/v) acetic acid] and in the second dimension, for 16 min at 1500 V in pH 3.5 buffer [0.5% (v/v) pyridine, 5% (v/v) acetic acid]. Phosphoamino acid markers were visualized by staining with 0.2% ninhydrin dissolved in acetone.
Chymotryptic digestion
Digestions were performed widi radiolabeled 70K protein that had been eluted from an SDS-PAGE gel as described (2) . Typically, 70 /J of 50 mM NH4HCO3 were added to a 20 y\ sample containing ~ 0.2 /tg 70K protein in gel elution buffer (10 mM NH4HCO3, 0.5% SDS and 0.5% /3-mercaptoethanol), followed by 10 /tg of freshly prepared chymotrypsin (1 mg/ml in 50 mM NH4HCO3), and incubated at 37 °C for 15 to 240 min. The samples were lyophilized prior to SDS-PAGE analysis. Figure 1 . Phosphorylation of the Ul-specific 70K protein. Ul, U2, U4AJ6 and U5 snRNPs were isolated from SIR nuclear extract, prepared from HeLa cells grown in either the absence or presence of ^P-orthophosphate, by immunoaffinity chromatography (see Methods). Unlabekd, immunoaffinity purified Ul -U6 snRNPs were phosphorylated in vitro as described in Materials and Methods. Protein isolated from 50 /ig of in vivo fleft panel) or in vitro (right panel) 32 P-phosphorylated snRNPs was subjected to two-dimensional PAGE (isoelectric focusing in a pH 3 -11 gradient followed by 15% SDS-PAGE). The coomassie-stained 2-D gels are displayed in the upper panels, while the corresponding autoradiograms are shown in the lower. The positions of snRNP proteins and of the 70K isoelectric variants are indicated. An identical pattern is observed with snRNPs isolated from splicing extracts.
RESULTS
The Ul snRNP 70K protein kinase is associated with purified snRNPs
We have previously demonstrated through the in vivo labeling of HeLa cells with ^P-orthophosphate that the Ul snRNPassociated 70K protein is phosphorylated in vivo (2) . Twodimensional PAGE analysis further revealed that all of the previously identified 70K isoelectric variants are phosphorylated. To test whether the phosphotransferase activity responsible for 70K protein phosphorylation is associated with snRNPs, Ul -U6 snRNPs which had been purified from HeLa nuclear extract by anti-m 3 G immunoaffinity chromatography were incubated with gamma-pPJ-ATP and the phosphorylation of snRNP-associated proteins analysed by two-dimensional PAGE. For comparison, in vivo 32 P-labeled, U1-U6 snRNPs, isolated in an identical manner, were also analysed. As shown in Figure 1 , a kinase activity which selectively phosphorylates all of the 70K protein isoelectric variants is present in affinity purified snRNPs. Identical results are obtained with snRNPs isolated either from SIR or splicing extracts. As previously observed with in vivo labeled 70K protein, the extent of in vitro ^P-incorporation for each variant directly correlates with its mass (compare coomassie stained gel with autoradiograph), suggesting that each 70K variant is phosphorylated to a similar extent.
Additional in vitro phosphorylation studies with Mono Q purified snRNPs indicate that the snRNP-associated U1-70K kinase is predominantly, although not exclusively, associated with Ul snRNPs (data not shown). Kinase activity does not require an intact RNP particle, since 70K phosphorylation is observed P-ser*,, , p , hr 6 in vitro Figure 2 . Pbosphoamino acid analysis of phosphorylated 70K protein. ^P-labcled 70K protein (600 cpm) was isolated from in vivo (upper panel) or in vitro (lower panel) phosphorylated snRNPs, hydrolyzed, and the resultant amino acids separated by two-dimensional thin-layer electrophoresjs as described in the Methods section. ^P-labeled amino acids were detected by autoradiography and identified by comigrauon with internal standards of pbosphoserine (P-ser), phosphothreomne (P-thr), and phosphotyrosine (P-tyr) which were visualized by staining with ninhydrin. The positions of these standards are indicated by dotted circles. Small circles indicate the site of sample application. The left, upper most spot in both panels is free phosphate (Pj) which is generated by the hydrolysis of amino acidphosphate bonds during the acid hydrolysis step. with RNase-digested snRNPs or with purified snRNP proteins which have been dissociated from snRNA (data not shown). Additionally, in vitro phosphorylation studies demonstrate that the snRNP-associated kinase preferentially utilizes ATP as a phosphodonor; no significant 70K phosphorylation is observed with GTP or any other nucleotide, aside from ATP (not shown).
Serine residues of the 70K protein are phosphorylated in vivo as well as in vitro To identify which amino acid residues of the 70K protein are phosphorylated in vivo and in vitro, ^-phosphorylated 70K was gel purified and subjected to phosphoamino acid analysis. After two-dimensional separation together with unlabeled phosphoamino acid references, a labeled spot corresponding to phosphoserine was observed with both in vivo and in vitro phosphorylated 70K protein (Fig.2) . Thus, the amino acid specificity of the in vivo 70K kinase is identical to that of the enzyme associated with immunoaffinity purified snRNPs.
An overlapping subset of radiolabeled phosphopeptides is observed with in vitro versus in vivo labeled 70K protein 32 P-labeled 70K protein was isolated from both in vivo and in vitro phosphorylated snRNPs and digested to completion with trypsin. The resultant tryptic peptides were fractionated by two dimensional thin layer chromatography. As shown in the upper left panel of Figure 3 , eight radiolabeled peptides (designated a-h) are observed in the in vivo labeled protein (the unlabeled spot to the left of f is not reproducibly observed), indicating at least eight different phosphorylation sites. Since seven identical SR dipeptides, one or more of which could be phosphorylated, are theoretically expected upon digestion with trypsin, there are potentially as many as fifteen phosphorylation sites. By comparison, proteolysis of the in vitro labeled 70K yields four phosphopeptides which appear to be identical to those of the in vivo labeled sample designated a, b, d, and g. To test whemer these peptides are indeed identical, a mixture of the in vivo and in vitro phosphopeptides was analysed (Fig.3, lower middle  panel) . The exact comigration of peptides from each sample indicate that peptides a, b, d, and g of the in vitro phosphorylated sample possess amino acid sequences identical to those of the in vivo labeled sample. Thus, identical, albeit fewer, phosphorylation sites are present after in vitro phosphorylation. These results strongly suggest that the snRNP-associated serine kinase is responsible, at least in part, for the observed in vivo phosphorylation of the U1-70K protein.
The multiple U1-70K phosphorylation sites are clustered in a carboxy-terminal domain
Phosphopeptide analysis demonstrated multiple (at least four) in vitro phosphorylation sites within the U1-70K protein. In order to map these sites, in vitro ^P-labeled 70K protein was digested with chymotrypsin for various lengths of time and the products separated by SDS-PAGE. As shown in Figure 4A , chymotryptic digestion yields only one labeled fragment with an apparent molecular weight of 23 kd (identical results are obtained with in vivo labeled protein). The fact that only one radiolabeled fragment is generated, even after lengthy digestion times, indicates that proteolysis was complete. The sequence of the U1-70K protein, with the predicted sites of chymotryptic cleavage indicated, is presented in Figure 5B . A compilation of all of the expected fragments and their molecular weights is also depicted in Table 1 out with a 32 amino acid long synthetic peptide corresponding to residues 349-380 (see Fig.5B ). As shown in Figure 4B , this peptide was efficiently phosphorylated by kinase active Ul snRNPs (at the expense of 70K phosphorylation), providing further evidence that phosphorylation of the 70K protein is limited to the 23 kd region defined by chymotryptic proteolysis. Upon close inspection, it is apparent that this region of the 70K protein contains several arginine/serine rich clusters ( Fig.5A and B) . The predominance of potential phosphorylation sites consisting of an RS motif prompted us to investigate whether other proteins containing similar motifs could be phosphorylated by the snRNPassociated, serine kinase.
The snRNP-associated kinase phosphorylates the RS domain of ASF/SF2
Sequence analysis of alternative splicing factor (ASF/SF2) revealed a carboxy terminal domain consisting of multiple, repetitive RS dimers (8, 9) . The suitability of this domain as a substrate for the snRNP-associated serine kinase was tested by incubating bacterially expressed, recombinant ASF/SF2, several deletion mutants, and ASF-3 with kinase-active, purified Ul snRNPs and gamma-[ 32 P]-ATP. As shown in Figure 6A , lanes 1 and 2, ASF/SF2 is efficiently phosphorylated, whereas ASF-3, an alternative splicing variant which lacks an RS-rich domain, is not (lanes 3 and 4) . The RS-domain as the site of phosphorylation is further confirmed by the results obtained with various ASF/SF2 deletion mutants (lanes 5 -12). Removal of 24 amino acids from the C-terminus (mutant A) has little effect Collection of all theoretical 70K peptides generated by chymotryptic digestion and their expected molecular weight.
on the efficiency of in vitro phosphorylation. Deletion of an additional 24 amino acids (mutant B) completely inhibits ^P-incorporation, suggesting that the majority of phosphorylation sites are located within residues 200-224. A low level of phosphorylation is observed with mutant D which contains only the C-terminal most 20 amino acids of the RS domain, suggesting that additional phosphorylation sites are located in this region as well.
DISCUSSION
In this paper we have demonstrated the presence of an enzymatic activity in UsnRNPs (Ul, U2, U5, and U4/U6) which had been immunoaffinity purified from HeLa cell nuclear extract. This snRNP-associated enzyme was shown to phosphorylate the Ul-specific 70K protein in vitro. In vivo and in vitro phosphorylated 70K share several properties, providing evidence that the snRNP-associated kinase is responsible for the in vivo phosphorylation of this protein. In both instances, all thirteen 70K isoelectric variants are phosphorylated and serine residues are the sole recipients of a phosphate group (see Fig. 1 and 2 ). More importantly, four identical phosphopeptides are generated upon tryptic digestion of the in vivo and in vitro labeled protein, indicating both are phosphorylated at identical sites (see Fig. 3 ). The presence of four additional in vivo radiolabeled peptides (i.e., a total of eight) suggests that one or more additional serine kinases, distinct from the snRNP-associated one, may be involved in 70K phosphorylation. Alternatively, several sites normally phosphorylated by the snRNP-associated kinase in vivo, could be unaccessible to the enzyme in vitro, or, since at least partial dephosphorylation is required for the in vitro incorporation of gamma-t^J-ATP, they could be extensively phosphorylated in the isolated Ul snRNP. Nonetheless, our results suggest that the phosphorylation of the 70K protein in vivo is attributed, at least in part, to the activity of the snRNP-associated enzyme. We cannot, however, exclude the possibility that additional serine kinases with an overlapping substrate specificity also contribute to the in vivo phosphorylation of one or more sites recognized by the snRNP-associated kinase.
The serine kinase co-purifing with snRNPs appears to be relatively stably-associated with at least one of the snRNP particles, since Ul snRNPs fractionated by Mono Q column chromatography retain significant kinase activity. However, despite its apparent preferential association with Ul, there is evidence against a particle-specific association, since other snRNP species appear to possess the U1-70K kinase activity as well (not shown). In addition, although associated with snRNP particles, kinase activity is not dependent upon an intact RNP structure. Purified snRNP proteins, prepared free of snRNA as described by Sumpter et al. (30) , or particles treated with RNase A, still retain the ability to phosphorylate the U1-70K protein.
Preliminary fractionation studies indicate that the U1-70K kinase is a minor protein distinct from the thus far identified snRNP proteins (Fetzer et al., unpublished results) . Due to its apparent low abundance (relative to previously characterized snRNP proteins), we cannot rule out that this enzyme represents a contaminant rather than a bonafide snRNP component. However, retention of the U1-70K kinase even after several purification steps, including immunoaffinity chromatography, glycerol gradient centrifugation and Mono Q chromatography, suggests a physical association of the kinase with, at least, the Ul snRNP particle. This association may arise by its interaction with the 70K protein during phosphorylation; a stable association between a kinase and its preferred substrate has been reported for nucleolar protein kinase Nil and nucleolin (31) .
Several lines of evidence indicate that the multiple 70K phosphorylation sites are confined to serine residues in the Cterminal half of the protein. When either in vivo or in vitro ^P-labeled 70K protein was subjected to chymotryptic proteolysis (see Fig.4A ) radioactivity was confined to a single digestion product with an apparent molecular weight of 23 kd. A comparison with the theoretically expected chymotryptic fragments ( Fig.5B and Table 1 ), suggested that it corresponded to a 23 kd fragment encompassing much of the C-terminal half of 70K. Since potential chymotryptic cleavage sites could be inactivated by amino acid modification, the observed 23 kd fragment could consist of two or more uncleaved, smaller fragments. This is, however, relatively unlikely, since all other theoretical cleavage products are very small and, thus, the generation of a 23 kd fragment would require the inactivation of multiple, consecutive cleavage sites. The presumed identity of this phosphorylated fragment was confirmed by the observed efficient in vitro phosphorylation of a synthetic peptide which comprises 32 residues (349 to 380) of the proposed phosphorylated 70K region. The absence of phosphorylation sites in the most N-terminal third of the protein was demonstrated by in vitro phosphorylation studies with an N-terminal fragment of the 70K protein (not shown).
The unique character of the phosphorylated region of the 70K protein led to an initial hypothesis regarding the amino acid sequences preferentially recognized by the snRNP-associated serine kinase. In particular, this domain is highly charged and contains a high percentage of arginine and, to a lesser extent, serine residues. As mentioned above, similar RS-rich domains have been documented in a number of splicing factors, including ASF/SF2, both subunits of U2AF, SC35, and the Drosophila splicing regulators tra, tra-2, and su(w°). The likelihood that RS motifs are recognized and phosphorylated by the snRNPassociated enzyme is underscored when the potential phosphorylation sites within the 23 kd region of the 70K protein are compared (see Figure 5B) ; the majority of serine residues are flanked by an arginine residue. Tryptic phosphopeptide analysis of in vitro phosphorylated 70K demonstrated that four unique amino acid sequences serve as substrates for the serine kinase. Although sixteen serine residues are present in this region, only nine unique peptides are expected upon tryptic proteolysis, since seven identical SR dipeptides should be generated. While the majority of unique tryptic peptides contain serines flanked by arginine, four of these fragments, and thus four potential phosphorylation sites, do not. The results of in vitro phosphorylation with the synthetic 32mer provided the first direct evidence that the U1-70K protein kinase may preferentially phosphorylate serines flanked by arginine; both serine residues within this peptide fall into this catagory. Preliminary phosphorylation studies with additional peptides of varying sequence supported this hypothesis as well (not shown). Significant support is further provided by the results of the in vitro phosphorylation studies utilizing the splicing factor ASF/SF2 (see below).
While additional studies are clearly needed before a consensus phosphorylation site can be assigned to the snRNP-associated kinase, its apparent affinity for serine residues preceeded or flanked by arginine residues suggests that it may be a novel member of the serine/threonine class of protein kinases. Few of the well-studied serine/threonine kinases phosphorylate serine residues either preceeded or flanked by arginine (32) . Two wellstudied kinases which fit into this catagory are cyclic nucleotidedependent enzymes which phosphorylate histone H2B (32) . The absence of cyclic nucleotides in the in vitro kinase reaction demonstrates the cyclic nucleotide independence of the snRNPassociated kinase; by analogy it must also not require calcium or diacylglycerol, two additional well-documented kinase activators. The inability of this kinase to phosphorylate casein or histone HI (data not shown), further distinguishes it from casein kinase I and protein kinase C, respectively. Although it is tempting to speculate that the snRNP-associated kinase belongs to a previously unidentified group of serine kinases, such conclusions are premature in the absence of additional information. A more detailed characterization of this snRNPassociated kinase is clearly warranted and may require its purification to homogeneity.
Important evidence for the substrate specificity and potential general role of the snRNP-associated kinase in splicing regulation was provided by in vitro phosphorylation studies with recombinant ASF/SF2, ASF-3, and the deletion mutants. Efficient phosphorylation of ASF/SF2, but not ASF-3 was observed (see Fig.6 ). Since ASF-3 differs from ASF/SF2 primarily at its carboxy terminus (i.e., the RS-rich region is absent), these results already indicated that phosphorylation by the snRNP-associated kinase is confined to the RS-rich domain. The availability of ASF/SF2 mutants lacking various regions of the RS domain allowed us to map more precisely the sites of ASF phosphorylation. The significant loss of ^P-incorporation upon deletion of residues 200 to 224, demonstrated that the majority of phosphorylation sites are located in this region. Interestingly, this segment is comprised almost exclusively of ten RS repeats; of the eleven serine residues present, only one is not flanked by arginine (see Fig.6C ). Additional phosphorylation sites were also detected in the most C-terminal 20 amino acids. Not surprisingly, this region also contains several RS dipeptides.
By analogy with the U1-70K protein, our results suggest that the snRNP-associated kinase may also be responsible for the apparent in vivo phosphorylation of ASF/SF2. They additionally raise the question as to whether other splicing factors which contain RS-rich domains may be phosphorylated by this kinase as well. The functional importance of the RS domain of U2AF and ASF/SF2 has recently been demonstrated (10, 17) . In both instances, deletion of this domain abolishes the factor's function in constitutive pre-mRNA splicing, although its RNA binding capacity is maintained. In the case of ASF/SF2, which carries out dual functions, acting in both constitutive and alternative premRNA splicing, deletion of the RS domain does not affect its capability to influence splice site selection (17) . Interestingly, residues 200-224, corresponding to the heavily phosphorylated region described here, are necessary and sufficient to provide RS function in the constitutive splicing assay (17) . In light of these results, the potential functional significance of modifying this region through phosphorylation is readily apparent. Due to the highly basic nature of such RS-rich domains, they have been postulated to mediate binding to RNA through electrostatic interactions (3), or conceivably interactions with other proteins. Phosphorylation (and subsequent dephosphorylation) could modulate an electrostatic-based interaction of this region with other molecules, for example, during spliceosome formation or splicing proper. The phosphorylation of ASF/SF2 (or other factors such as SC35 and U2AF) could be temporally regulated by means of the 70K protein kinase's association with snRNPs. That is, the Ul snRNP, for example, could act as a chaperone, bringing the enzyme into close proximity to the above mentioned factors during pre-spliceosome assembly.
The potential significance of protein phosphorylation in the regulation of splicing is underscored by its well documented role in the regulation of countless other biochemical processes. A number of recent studies have provided evidence mat protein phosphorylation/dephosphorylation cycles play a significant role in pre-mRNA splicing. In particular, serine/threonine phosphatase activity has been shown to be essential for die first and second steps of splicing (21, 22) . Tazi et al. have provided evidence that one potential target of these phosphatases may be the U1-70K protein (23) . In vitro phosphorylated Ul snRNPs were added to splicing extracts which had been depleted of their endogeneous Ul and their ability to complement the splicing-inactive extracts tested. Ul particles containing normally phosphorylated 70K restored splicing, whereas those particles phosphorylated with S-ATP did not. Since 35 S-phosphorylated 70K was not dephosphorylated in splicing extracts (in contrast to 32 P-phosphorylated protein), these results suggested that the dephosphorylation of the 70K protein was crucial for its in vitro splicing activity. Our results suggest that an additional target of the serineAhreonine phosphatases may be ASF/SF2. We are currently utilizing in vitro splicing complementation assays to test whether the phosphorylation state of the ASF/SF2 RS domain affects its activity in constitutive pre-mRNA splicing.
